# NUSCALE POWER Corp: financial statements, quarterly SMR · NYSE · CIK 1822966 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/smr.md) · [Financials](/companies/smr/financials.md) · [Filings](/companies/smr/filings.md) · [Insiders](/companies/smr/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/smr/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [7.0](/filings/0001822966-24-000144.md) | [4.6 d](/filings/0001822966-26-000018.md) | [1.4](/filings/0001822966-25-000088.md) | [1.0](/filings/0001822966-25-000133.md) | [0.5](/filings/0001822966-25-000175.md) | [34.2 d](/filings/0001822966-26-000018.md) | [13.4](/filings/0001822966-26-000054.md) | [8.1](/filings/0001822966-26-000085.md) | [8.2](/filings/0001822966-25-000175.md) | [1.8 d](/filings/0001822966-26-000018.md) | [0.6](/filings/0001822966-26-000054.md) | [0.1](/filings/0001822966-26-000085.md) | | Cost of revenue | $m | [5.9](/filings/0001822966-24-000144.md) | [3.8 d](/filings/0001822966-26-000018.md) | [0.7](/filings/0001822966-25-000088.md) | [0.9](/filings/0001822966-25-000133.md) | [0.3](/filings/0001822966-25-000175.md) | [3.1 d](/filings/0001822966-26-000018.md) | [6.4](/filings/0001822966-26-000054.md) | [6.3](/filings/0001822966-26-000085.md) | [5.5](/filings/0001822966-25-000175.md) | [1.9 d](/filings/0001822966-26-000018.md) | [0.5](/filings/0001822966-26-000054.md) | [0.2](/filings/0001822966-26-000085.md) | | Gross profit | $m | [1.0](/filings/0001822966-24-000144.md) | [0.7 d](/filings/0001822966-26-000018.md) | [0.6](/filings/0001822966-25-000088.md) | [0.1](/filings/0001822966-25-000133.md) | [0.2](/filings/0001822966-25-000175.md) | [31.2 d](/filings/0001822966-26-000018.md) | [7.0](/filings/0001822966-26-000054.md) | [1.8](/filings/0001822966-26-000085.md) | [2.7](/filings/0001822966-25-000175.md) | [(0.1) d](/filings/0001822966-26-000018.md) | [0.0](/filings/0001822966-26-000054.md) | [(0.2)](/filings/0001822966-26-000085.md) | | Research and development | $m | [63.7](/filings/0001822966-24-000144.md) | [37.8 d](/filings/0001822966-26-000018.md) | [13.2](/filings/0001822966-25-000088.md) | [12.1](/filings/0001822966-25-000133.md) | [12.2](/filings/0001822966-25-000175.md) | [9.4 d](/filings/0001822966-26-000018.md) | [9.1](/filings/0001822966-26-000054.md) | [11.8](/filings/0001822966-26-000085.md) | [11.1](/filings/0001822966-25-000175.md) | [13.5 d](/filings/0001822966-26-000018.md) | [12.8](/filings/0001822966-26-000054.md) | [18.4](/filings/0001822966-26-000085.md) | | Operating income | $m | [(92.9)](/filings/0001822966-24-000144.md) | [(71.1) d](/filings/0001822966-26-000018.md) | [(44.0)](/filings/0001822966-25-000088.md) | [(41.9)](/filings/0001822966-25-000133.md) | [(41.0)](/filings/0001822966-25-000175.md) | [(11.9) d](/filings/0001822966-26-000018.md) | [(35.3)](/filings/0001822966-26-000054.md) | [(43.1)](/filings/0001822966-26-000085.md) | [(538)](/filings/0001822966-25-000175.md) | [(72.7) d](/filings/0001822966-26-000018.md) | [(57.5)](/filings/0001822966-26-000054.md) | [(64.0)](/filings/0001822966-26-000085.md) | | Income tax | $m | [0.0](/filings/0001822966-24-000144.md) | [0.0 d](/filings/0001822966-26-000018.md) | [0.0](/filings/0001822966-24-000068.md) | [0.0](/filings/0001822966-24-000115.md) | [0.0](/filings/0001822966-24-000144.md) | [1.9 d](/filings/0001822966-26-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Net income | $m | [(19.1)](/filings/0001822966-24-000144.md) | [(18.8) d](/filings/0001822966-26-000018.md) | [(16.6)](/filings/0001822966-25-000088.md) | [(27.6)](/filings/0001822966-25-000133.md) | [(17.5)](/filings/0001822966-25-000175.md) | [(75.0) d](/filings/0001822966-26-000018.md) | [(14.0)](/filings/0001822966-26-000054.md) | [(17.6)](/filings/0001822966-26-000085.md) | [(273)](/filings/0001822966-25-000175.md) | [(50.8) d](/filings/0001822966-26-000018.md) | [(44.0)](/filings/0001822966-26-000054.md) | [(47.5)](/filings/0001822966-26-000085.md) | | Diluted EPS | $ per share | [(0.26)](/filings/0001822966-24-000144.md) | not reported | [(0.21)](/filings/0001822966-25-000088.md) | [(0.31)](/filings/0001822966-25-000133.md) | [(0.18)](/filings/0001822966-25-000175.md) | not reported | [(0.11)](/filings/0001822966-26-000054.md) | [(0.13)](/filings/0001822966-26-000085.md) | [(1.85)](/filings/0001822966-25-000175.md) | not reported | [(0.14)](/filings/0001822966-26-000054.md) | [(0.13)](/filings/0001822966-26-000085.md) | | Basic EPS | $ per share | [(0.26)](/filings/0001822966-24-000144.md) | not reported | [(0.21)](/filings/0001822966-25-000088.md) | [(0.31)](/filings/0001822966-25-000133.md) | [(0.18)](/filings/0001822966-25-000175.md) | not reported | [(0.11)](/filings/0001822966-26-000054.md) | [(0.13)](/filings/0001822966-26-000085.md) | [(1.85)](/filings/0001822966-25-000175.md) | not reported | [(0.14)](/filings/0001822966-26-000054.md) | [(0.13)](/filings/0001822966-26-000085.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [117](/filings/0001822966-23-000260.md) | [120](/filings/0001822966-25-000024.md) | [132](/filings/0001822966-24-000068.md) | [131](/filings/0001822966-24-000115.md) | [112](/filings/0001822966-24-000144.md) | [402](/filings/0001822966-26-000018.md) | [491](/filings/0001822966-25-000088.md) | [298](/filings/0001822966-25-000133.md) | [408](/filings/0001822966-25-000175.md) | [836](/filings/0001822966-26-000085.md) | [341](/filings/0001822966-26-000054.md) | [766](/filings/0001822966-26-000085.md) | | Current assets | $m | [159](/filings/0001822966-23-000260.md) | [155](/filings/0001822966-25-000024.md) | [157](/filings/0001822966-24-000068.md) | [156](/filings/0001822966-24-000115.md) | [181](/filings/0001822966-24-000144.md) | [471](/filings/0001822966-26-000018.md) | [543](/filings/0001822966-25-000088.md) | [443](/filings/0001822966-25-000133.md) | [720](/filings/0001822966-25-000175.md) | [1,273](/filings/0001822966-26-000085.md) | [908](/filings/0001822966-26-000054.md) | [1,101](/filings/0001822966-26-000085.md) | | Total assets | $m | [309](/filings/0001822966-23-000260.md) | [225](/filings/0001822966-25-000024.md) | [230](/filings/0001822966-24-000068.md) | [229](/filings/0001822966-24-000115.md) | [253](/filings/0001822966-24-000144.md) | [545](/filings/0001822966-26-000018.md) | [618](/filings/0001822966-25-000088.md) | [606](/filings/0001822966-25-000133.md) | [883](/filings/0001822966-25-000175.md) | [1,413](/filings/0001822966-26-000085.md) | [1,148](/filings/0001822966-26-000054.md) | [2,049](/filings/0001822966-26-000085.md) | | Current liabilities | $m | [81.5](/filings/0001822966-23-000260.md) | [87.5](/filings/0001822966-25-000024.md) | [85.1](/filings/0001822966-24-000068.md) | [58.8](/filings/0001822966-24-000115.md) | [80.6](/filings/0001822966-24-000144.md) | [89.7](/filings/0001822966-26-000018.md) | [87.3](/filings/0001822966-25-000088.md) | [105](/filings/0001822966-25-000133.md) | [446](/filings/0001822966-25-000175.md) | [296](/filings/0001822966-26-000085.md) | [30.9](/filings/0001822966-26-000054.md) | [29.1](/filings/0001822966-26-000085.md) | | Total liabilities | $m | [129](/filings/0001822966-23-000260.md) | [95.5](/filings/0001822966-25-000024.md) | [101](/filings/0001822966-24-000068.md) | [136](/filings/0001822966-24-000115.md) | [163](/filings/0001822966-24-000144.md) | [91.6](/filings/0001822966-26-000018.md) | [88.6](/filings/0001822966-25-000088.md) | [108](/filings/0001822966-25-000133.md) | [448](/filings/0001822966-25-000175.md) | [299](/filings/0001822966-26-000085.md) | [38.4](/filings/0001822966-26-000054.md) | [35.5](/filings/0001822966-26-000085.md) | | Shareholders' equity | $m | [106](/filings/0001822966-23-000260.md) | [93.5](/filings/0001822966-25-000024.md) | [125](/filings/0001822966-24-000068.md) | [136](/filings/0001822966-24-000115.md) | [160](/filings/0001822966-24-000144.md) | [619](/filings/0001822966-26-000018.md) | [704](/filings/0001822966-25-000088.md) | [693](/filings/0001822966-25-000133.md) | [829](/filings/0001822966-25-000175.md) | [1,169](/filings/0001822966-26-000085.md) | [1,167](/filings/0001822966-26-000054.md) | [2,061](/filings/0001822966-26-000085.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(27.7) d](/filings/0001822966-24-000144.md) | [(73.2) d](/filings/0001822966-26-000018.md) | [(33.5)](/filings/0001822966-25-000088.md) | [(36.0) d](/filings/0001822966-25-000133.md) | [(12.7) d](/filings/0001822966-25-000175.md) | [(26.4) d](/filings/0001822966-26-000018.md) | [(22.8)](/filings/0001822966-26-000054.md) | [(33.3) d](/filings/0001822966-26-000085.md) | [(200) d](/filings/0001822966-25-000175.md) | [(204) d](/filings/0001822966-26-000018.md) | [(315)](/filings/0001822966-26-000054.md) | [(58.2) d](/filings/0001822966-26-000085.md) | | Capital expenditure | $m | [0.1 d](/filings/0001822966-24-000144.md) | [0.1 d](/filings/0001822966-26-000018.md) | [0.0](/filings/0001822966-25-000088.md) | [0.0 d](/filings/0001822966-24-000115.md) | [0.0 d](/filings/0001822966-25-000175.md) | [0.0 d](/filings/0001822966-26-000018.md) | [0.1](/filings/0001822966-26-000054.md) | [(0.1) d](/filings/0001822966-26-000085.md) | [0.1 d](/filings/0001822966-25-000175.md) | [0.4 d](/filings/0001822966-26-000018.md) | [1.5](/filings/0001822966-26-000054.md) | [0.4 d](/filings/0001822966-26-000085.md) | | Share repurchases | $m | [0.0 d](/filings/0001822966-23-000260.md) | [0.0 d](/filings/0001822966-25-000024.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [46.4](/filings/0001822966-23-000260.md) | [69.7](/filings/0001822966-24-000068.md) | [72.1](/filings/0001822966-24-000115.md) | [74.8](/filings/0001822966-24-000144.md) | [79.6](/filings/0001822966-25-000088.md) | [89.6](/filings/0001822966-25-000133.md) | [95.2](/filings/0001822966-25-000175.md) | [128](/filings/0001822966-26-000054.md) | [133](/filings/0001822966-26-000085.md) | [148](/filings/0001822966-25-000175.md) | [320](/filings/0001822966-26-000054.md) | [365](/filings/0001822966-26-000085.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.